Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for International Journal of Endocrinology, enter your email address in the box below.

International Journal of Endocrinology
Volume 2009, Article ID 270698, 6 pages
http://dx.doi.org/10.1155/2009/270698
Research Article

Short Hypoxia Does not Affect Plasma Leptin in Healthy Men under Euglycemic Clamp Conditions

Andre Schmoller,1 Michaela Voss,1 Hartmut Gehring,2 Sebastian Rudolf,1 Ulrich Schweiger,1 Bernd Schultes,3 and Kerstin M. Oltmanns1,4

1Department of Psychiatry and Psychotherapy, University of Luebeck, D-23538 Luebeck, Germany
2Department of Anaesthesiology, University of Luebeck, D-23538 Luebeck, Germany
3Interdisciplinary Obesity Center, St. Gallen, CH-9400 Rorschach, Switzerland
4Department of Neuroendocrinology, University of Luebeck, D-23538 Luebeck, Germany

Received 15 January 2009; Accepted 12 March 2009

Academic Editor: Graeme Eisenhofer

Copyright © 2009 Andre Schmoller et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Hosogai, A. Fukuhara, K. Oshima et al., “Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation,” Diabetes, vol. 56, no. 4, pp. 901–911, 2007. View at Publisher · View at Google Scholar · View at PubMed
  2. K. M. Oltmanns, H. Gehring, S. Rudolf et al., “Hypoxia causes glucose intolerance in humans,” American Journal of Respiratory and Critical Care Medicine, vol. 169, no. 11, pp. 1231–1237, 2004. View at Google Scholar
  3. K. M. Oltmanns, H. Gehring, S. Rudolf et al., “Persistent suppression of resting energy expenditure after acute hypoxia,” Metabolism, vol. 55, no. 5, pp. 669–675, 2006. View at Publisher · View at Google Scholar · View at PubMed
  4. K. M. Oltmanns, H. Gehring, S. Rudolf et al., “Acute hypoxia decreases plasma VEGF concentration in healthy humans,” American Journal of Physiology, vol. 290, no. 3, pp. E434–E439, 2006. View at Publisher · View at Google Scholar · View at PubMed
  5. C. Hubold, K. M. Oltmanns, B. Schultes et al., “High plasma VEGF relates to low carbohydrate intake in patients with type 2 diabetes,” International Journal of Obesity, vol. 30, no. 9, pp. 1356–1361, 2006. View at Publisher · View at Google Scholar · View at PubMed
  6. J. Auwerx and B. Staels, “Leptin,” The Lancet, vol. 351, no. 9104, pp. 737–742, 1998. View at Publisher · View at Google Scholar
  7. K. Chin, K. Shimizu, T. Nakamura et al., “Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy,” Circulation, vol. 100, no. 7, pp. 706–712, 1999. View at Google Scholar
  8. I. A. Harsch, P. C. Konturek, C. Koebnick et al., “Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment,” European Respiratory Journal, vol. 22, no. 2, pp. 251–257, 2003. View at Publisher · View at Google Scholar
  9. M. Tschöp, C. J. Strasburger, G. Hartmann, J. Biollaz, and P. Bärtsch, “Raised leptin concentrations at high altitude associated with loss of appetite,” The Lancet, vol. 352, no. 9134, pp. 1119–1120, 1998. View at Publisher · View at Google Scholar
  10. E. M. Snyder, R. D. Carr, C. F. Deacon, and B. D. Johnson, “Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans,” Applied Physiology, Nutrition and Metabolism, vol. 33, no. 5, pp. 929–935, 2008. View at Publisher · View at Google Scholar · View at PubMed
  11. M. Zaccaria, A. Ermolao, P. Bonvicini, G. Travain, and M. Varnier, “Decreased serum leptin levels during prolonged high altitude exposure,” European Journal of Applied Physiology, vol. 92, no. 3, pp. 249–253, 2004. View at Google Scholar
  12. U. Meißner, C. Hänisch, I. Östreicher et al., “Differential regulation of leptin synthesis in rats during short-term hypoxia and short-term carbon monoxide inhalation,” Endocrinology, vol. 146, no. 1, pp. 215–220, 2005. View at Publisher · View at Google Scholar · View at PubMed
  13. A. Grosfeld, V. Zilberfarb, S. Turban, J. André, M. Guerre-Millo, and T. Issad, “Hypoxia increases leptin expression in human PAZ6 adipose cells,” Diabetologia, vol. 45, no. 4, pp. 527–530, 2002. View at Publisher · View at Google Scholar · View at PubMed
  14. T. Yasumasu, K. Takahara, and Y. Nakashima, “Hypoxia inhibits leptin production by cultured rat adipocytes,” Obesity Research, vol. 10, no. 2, p. 128, 2002. View at Google Scholar
  15. H. Raff, E. D. Bruder, B. M. Jankowski, and R. J. Colman, “Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat,” Hormone and Metabolic Research, vol. 33, no. 3, pp. 151–155, 2001. View at Publisher · View at Google Scholar
  16. B. Fruehwald-Schultes, K. M. Oltmanns, W. Kern, J. Born, H. L. Fehm, and A. Peters, “The effect of experimentally induced insulin resistance on the leptin response to hyperinsulinaemia,” International Journal of Obesity, vol. 26, no. 4, pp. 510–516, 2002. View at Publisher · View at Google Scholar
  17. P. Wellhoener, B. Fruehwald-Schultes, W. Kern et al., “Glucose metabolism rather than insulin is a main determinant of leptin secretion in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 3, pp. 1267–1271, 2000. View at Publisher · View at Google Scholar
  18. J. L. Chan, S. L. Wong, C. Orlova, P. Raciti, and C. S. Mantzoros, “Pharmacokinetics of recombinant methionyl human leptin after subcutaneous administration: variation of concentration-dependent parameters according to assay,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 6, pp. 2307–2311, 2007. View at Google Scholar
  19. A. C. de León, D. A. González, L. I. Pérez Méndez et al., “Leptin and altitude in the cardiovascular diseases,” Obesity Research, vol. 12, no. 9, pp. 1492–1498, 2004. View at Google Scholar
  20. P. Vats, V. K. Singh, S. N. Singh, and S. B. Singh, “High altitude induced anorexia: effect of changes in leptin and oxidative stress levels,” Nutritional Neuroscience, vol. 10, no. 5-6, pp. 243–249, 2007. View at Publisher · View at Google Scholar
  21. H. Raff, “Control of leptin with altitude exposure,” Journal of Applied Physiology, vol. 105, no. 5, pp. 1686–1687, 2008. View at Publisher · View at Google Scholar · View at PubMed
  22. J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, and B. D. Johnson, “Last word on viewpoint: effect of altitude on leptin levels, does it go up or down?,” Journal of Applied Physiology, vol. 105, no. 5, p. 1691, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, and B. D. Johnson, “Effect of altitude on leptin levels, does it go up or down?,” Journal of Applied Physiology, vol. 105, no. 5, pp. 1684–1685, 2008. View at Publisher · View at Google Scholar · View at PubMed
  24. T. W. Gettys, P. J. Harkness, and P. M. Watson, “The β3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes,” Endocrinology, vol. 137, no. 9, pp. 4054–4057, 1996. View at Publisher · View at Google Scholar
  25. H. Li, M. Matheny, and P. J. Scarpace, “β3-adrenergic-mediated suppression of leptin gene expression in rats,” American Journal of Physiology, vol. 272, no. 6, pp. E1031–E1036, 1997. View at Google Scholar
  26. A. Fritsche, H.-G. Wahl, E. Metzinger et al., “Evidence for inhibition of leptin secretion by catecholamines in man,” Experimental and Clinical Endocrinology and Diabetes, vol. 106, no. 5, pp. 415–418, 1998. View at Google Scholar
  27. S. Papaspyrou-Rao, S. H. Schneider, R. N. Petersen, and S. K. Fried, “Dexamethasone increases leptin expression in humans in vivo,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 5, pp. 1635–1637, 1997. View at Google Scholar
  28. S. Dagogo-Jack, G. Selke, A. K. Melson, and J. W. Newcomer, “Robust leptin secretory responses to dexamethasone in obese subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 82, no. 10, pp. 3230–3233, 1997. View at Publisher · View at Google Scholar
  29. M. K. Sinha, J. P. Ohannesian, M. L. Heiman et al., “Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects,” The Journal of Clinical Investigation, vol. 97, no. 5, pp. 1344–1347, 1996. View at Google Scholar
  30. H. S. Randeva, E. Karteris, K. C. Lewandowski, S. Sailesh, P. O'Hare, and E. W. Hillhouse, “Circadian rhythmicity of salivary leptin in healthy subjects,” Molecular Genetics and Metabolism, vol. 78, no. 3, pp. 229–235, 2003. View at Publisher · View at Google Scholar
  31. M. F. Saad, A. Khan, A. Sharma et al., “Physiological insulinemia acutely modulates plasma leptin,” Diabetes, vol. 47, no. 4, pp. 544–549, 1998. View at Publisher · View at Google Scholar
  32. N. Stefan, A. Fritsche, H. Häring, and M. Stumvoll, “Acute stimulation of leptin concentrations in humans during hyperglycemic hyperinsulinemia. Influence of free fatty acids and fasting,” International Journal of Obesity, vol. 25, no. 1, pp. 138–142, 2001. View at Publisher · View at Google Scholar
  33. T. U. Ciftci, O. Kokturk, N. Bukan, and A. Bilgihan, “Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome,” Respiration, vol. 72, no. 4, pp. 395–401, 2005. View at Publisher · View at Google Scholar · View at PubMed
  34. A. N. Vgontzas, D. A. Papanicolaou, E. O. Bixler et al., “Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia,” The Journal of Clinical Endocrinology & Metabolism, vol. 85, no. 3, pp. 1151–1158, 2000. View at Publisher · View at Google Scholar
  35. M. Drummond, J. C. Winck, J. T. Guimarães, A. C. Santos, J. Almeida, and J. A. Marques, “Autoadjusting-CPAP effect on serum leptin concentrations in obstructive sleep apnoea patients,” BMC Pulmonary Medicine, vol. 8, article 21, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  36. W. T. Gibson, I. S. Farooqi, M. Moreau et al., “Congenital leptin deficiency due to homozygosity for the Δ133G mutation: report of another case and evaluation of response to four years of leptin therapy,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 10, pp. 4821–4826, 2004. View at Publisher · View at Google Scholar · View at PubMed
  37. S. S. Martin, A. Qasim, and M. P. Reilly, “Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease,” Journal of the American College of Cardiology, vol. 52, no. 15, pp. 1201–1210, 2008. View at Publisher · View at Google Scholar · View at PubMed
  38. M. S. M. Ip, K. S. L. Lam, C.-M. Ho, K. W. T. Tsang, and W. Lam, “Serum leptin and vascular risk factors in obstructive sleep apnea,” Chest, vol. 118, no. 3, pp. 580–586, 2000. View at Google Scholar